According to @PelosiTracker_, a fifth U.S. politician this year has purchased IDEXX Laboratories shares, with Rep. Byron Donalds disclosing a $30,000 buy of IDXX. According to @PelosiTracker_, the post notes the National Biotech Initiative Act was introduced earlier this year to boost biotech funding but has not advanced since introduction. According to @PelosiTracker_, the stock is included in the account's Notable Politician portfolio on Autopilot and will be monitored closely. According to @PelosiTracker_, the disclosure concerns IDXX only and does not reference any cryptocurrency exposure or digital assets, indicating no direct crypto market linkage cited by the source.